Journals Library

HTA - 16/31/13

A phase 3 trial of Rivastigmine to prevent falls in Parkinson's Disease

Project title: A phase 3 trial of Rivastigmine to prevent falls in Parkinson's Disease

Call to action: 16/31 16/31 HTA CET, HTA EoI to Full Form, closing 10 August 2016

Research type: Primary Research

Chief investigator: Dr Emily Henderson

Contractor: Royal United Hospital Bath NHS Foundation Trust

Cost: £2,101,487.11

Co-investigators: Dr Alan Whone, Mrs Diana Steeds, Professor Chris Metcalfe, Professor William Hollingworth, Professor Yoav Ben-Shlomo.

Started: April 2018 | Status: Research in progress

ISRCTN: 41639809

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.

Background & Research Questions

Why the research is being done and what is being asked


How the research is being done

Publications & Outputs

What the research produced

Outcomes & Impact

What happened as a result of the research

If you would like to receive a notification when this project is updated, please submit your email address below. This will also notify you when the Journals Library report is published.